A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma
一项前瞻性、开放标签、多中心、观察性研究,旨在评估硼替佐米-美法仑-泼尼松作为自体干细胞移植不适宜的多发性骨髓瘤患者初始治疗的疗效和安全性。
期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.16790
Kim, Min Kyoung; Kim, Kihyun; Min, Chang-Ki; Kwak, Jae-Yong; Bae, Sang-Byung; Yoon, Sung-Soo; Lee, Je-Jung; Kim, Ki Hwan; Nam, Seung-Hyun; Mun, Yeung-Chul; Kim, Hyo Jung; Bae, Sung Hwa; Shin, Ho-Jin; Lee, Jung-Hee; Park, Joon Seong; Jeong, Seong Hyun; Lee, Mark Hong; Kim, Yang-Soo; Lee, Ho Sup; Park, Keon Woo; Lee, Won-Sik; Lee, Sang Min; Lee, Jeong-Ok; Hyun, Myung Soo; Jo, Deog Yeon; Lim, Sung-Nam; Lee, Jae Hoon; Cho, Do-Yeun; Do, Young Rok; Kim, Jeong-A; Park, Seong Kyu; Kim, Jin Seok; Kim, Soo-Jeong; Kim, Hawk; Yi, Hyeon Gyu; Moon, Joon Ho; Choi, Chul Won; Kim, Sung-Hyun; Joo, Young-Don; Kim, Hoon-Gu; Kim, Byung Soo; Park, Moo-Rim; Song, Moo-Kon; Kim, Su-Youn